Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Oct 31:14:793.
doi: 10.1186/1471-2407-14-793.

Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis

Wenwen Zhang, Wenjing Jiang, Linlin Luan, Lili Wang, Xiangrong Zheng, Gongchao Wang  1
Affiliations
Meta-Analysis

Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis

Wenwen Zhang et al. BMC Cancer. .

Abstract

Background: Small cell lung cancer (SCLC) accounts for about 13% of all lung cancer cases. Small cell lung cancer (SCLC) accounts for about 13% of all lung cancer cases. The purpose of the present article is to assess the role of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) by performing a systematic review of the randomized trials published in the literature.

Methods: Randomized controlled trials were identified that compared brain metastases incidence and overall survival between PCI and No PCI in patients with SCLC. Search strategies were limited to the English language and to articles published since 1997, and included: databases searched from 1997 to March 2013 -CINAHL, Embase, Medline, Web of Science, and CENTRAL. Methodological quality was assessed with the Jadad scale. The main end points were brain metastasis and survival.

Results: The review identified 5 trials, although few were of high quality. Two trials reported the one-year incidence of brain metastasis. PCI reduced the incidence of brain metastasis in one year, with a pooled relative risk of 0.45 (95% CI, 0.35 to 0.58; P < 0.00001). Four trials described the one year survival rate. The combined result revealed a significant (P = 0.01) survival benefit in the group assigned to PCI as compared with the control group, with a pooled relative risk of 0.87 (95% CI, 0.79 to 0.97). Three trials reported the three-year survival rate. The combined result revealed a great significant (P < 0.00001) survival benefit in the PCI group as compared with the No PCI group, with a pooled relative risk of 0.87 (95% CI, 0.83 to 0.91). the Five-year survival rate was compared in four trials Compared with the No PCI group, the PCI group had a significant (P < 0.00001) survival benefit with a pooled relative risk of 0.92 (95% CI, 0.88 to 0.95).

Conclusions: The present systematic review indicates that PCI decreases brain metastases incidence and that PCI improves survival in SCLC patients. Prophylactic cranial irradiation should be part of standard care for all patients with small-cell lung cancer who have a response to initial chemotherapy, and it should be part of the standard treatment in future studies involving these patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative-risk plots for brain metastasis of 1 year.
Figure 2
Figure 2
Relative-risk plots for death of 1 year in patients with SCLC.
Figure 3
Figure 3
Adjusted relative-risk plots for death of 1 year.
Figure 4
Figure 4
Relative-risk plots for death of 3 year.
Figure 5
Figure 5
Relative-risk plots for death of 5 year.
See this image and copyright information in PMC

References

    1. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol. 2006;24:4539–4544. doi: 10.1200/JCO.2005.04.4859. - DOI - PubMed
    1. Brade AM, Tannock IF. Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure? J Clin Oncol. 2006;24:1020–1022. doi: 10.1200/JCO.2005.04.9676. - DOI - PubMed
    1. Jackman DM, Johnson B. Small-cell lung cancer. Lancet. 2005;366:1385–1396. doi: 10.1016/S0140-6736(05)67569-1. - DOI - PubMed
    1. Stupp R, Monnerat C, Turrisi AT. Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 2004;45:105–117. doi: 10.1016/j.lungcan.2003.12.006. - DOI - PubMed
    1. Komaki R, Cox JD, Whitson W. Risk of brain metastases from small-cell carcinoma of the lung related to the length of survival and prophylactic irradiation. Cancer Treat Rep. 1981;65:811–814. - PubMed
Pre-publication history
    1. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/14/793/prepub